GLPwatch
Papers (9189)
Page 78 of 154, ranked by citation count.
- Effects of Exendin-4 on pancreatic islets function in treating hyperglycemia post severe scald injury in rats.
- The GLP-1 agonist semaglutide ameliorates cognitive regression in P301S tauopathy mice model via autophagy/ACE2/SIRT1/FOXO1-Mediated Microglia Polarization.
- Population pharmacokinetic of paracetamol and atorvastatin with co-administration of semaglutide.
- Liraglutide promotes apoptosis of HepG2 cells by activating JNK signaling pathway.
- Comparison of the effects of Liraglutide, Tirzepatide, and Retatrutide on diabetic kidney disease in db/db mice.
- The protective effects of liraglutide in reducing lipid droplets accumulation and myocardial fibrosis in diabetic cardiomyopathy.
- Tirzepatide: Clinical review of the "twincretin" injectable.
- Dermal Hypersensitivity Reaction to Semaglutide: Two Case Reports.
- Applications of peptide hormone ligands for the treatment of dumping and short bowel syndrome.
- Maturity-Onset diabetes of the young type 5 treated with the glucagon-like peptide-1 receptor agonist: A case report.
- Cyclic adenosine monophosphate critically modulates cardiac GLP-1 receptor's anti-inflammatory effects.
- The glucagon-like peptide-1 analog exendin-4 antagonizes the effect of acyl ghrelin on the respiratory exchange ratio.
- Glucagon-like receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits.
- Reframing appetitive reinforcement learning and reward valuation as effects mediated by hippocampal-dependent behavioral inhibition.
- Separation of exenatide analogue mono-PEGylated with 40 kDA polyethylene glycol by cation exchange chromatography.
- Potential role of tirzepatide towards Covid-19 infection in diabetic patients: a perspective approach.
- GLP-1 modulated the firing activity of nigral dopaminergic neurons in both normal and parkinsonian mice.
- Management of obesity with semaglutide or metformin in patients with antipsychotic-induced weight gain (MOSA): a non-randomised open-label pilot study.
- Liraglutide and Renal Outcomes in Type 2 Diabetes.
- Targeted pH switched europium complexes monitoring receptor internalisation in living cells.
- The promise of tirzepatide: A narrative review of metabolic benefits.
- Glucagon-like peptide-1 control of GnRH secretion in female sheep.
- A pilot clinical study to Evaluate Liraglutide-mediated Anti-platelet activity in patients with type-2 Diabetes (ELAID study).
- Semaglutide and the future of obesity care in the UK.
- Cannabinoid receptor 1 antagonist treatment induces glucagon release and shows an additive therapeutic effect with GLP-1 agonist in diet-induced obese mice.
- Fast-track rescue weight reduction therapy to achieve rapid technical operability for emergency bariatric surgery in patients with life-threatening inoperable severe obesity - A proof of concept study.
- Exenatide as an adjunct to nicotine patch for smoking cessation and prevention of postcessation weight gain among treatment-seeking smokers with pre-diabetes and/or overweight: study protocol for a randomised, placebo-controlled clinical trial.
- Characterization of a site-specific PEGylated analog of exendin-4 and determination of the PEGylation site.
- Long-Term Effectiveness and Cost-Effectiveness of Metformin Combined with Liraglutide or Exenatide for Type 2 Diabetes Mellitus Based on the CORE Diabetes Model Study.
- Effects of semaglutide and empagliflozin on oxygenation, vascular autoregulation, and central thickness of the retina in people with type 2 diabetes: A prespecified secondary analysis of a randomised clinical trial.
- The role of clusterin on pancreatic beta cell regeneration after exendin-4 treatment in neonatal streptozotocin administrated rats.
- Storage and Utilization of Glycogen by Mouse Liver during Adaptation to Nutritional Changes Are GLP-1 and PASK Dependent.
- The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Patients with Type 2 Diabetes (TROPHIES): Patient disposition, clinical characteristics and treatment persistence at 12 months.
- Effect of exenatide on fat deposition and a metabolic profile in patients with metabolic syndrome.
- Improved metabolic efficacy of a dual amylin and calcitonin receptor agonist when combined with semaglutide or empagliflozin.
- Superior Diagnostic Performance of the GLP-1 Receptor Agonist [Lys<sup>40</sup>(AhxHYNIC-[<sup>99m</sup>Tc]/EDDA)NH<sub>2</sub>]-Exendin-4 over Conventional Imaging Modalities for Localization of Insulinoma.
- Clinical Impact of Tirzepatide on Patients With OSA and Obesity.
- Cardiovascular outcomes of semaglutide and tirzepatide for patients with type 2 diabetes in clinical practice.
- Alternative dosing regimens of GLP-1 receptor agonists may reduce costs and maintain weight loss efficacy.
- Exendin-4 attenuates ischemia-induced ventricular arrhythmias in rats.
- A 4-arm polyethylene glycol derivative conjugated with exendin-4 peptide and palmitylamine having dual-function of size-increase and albumin-binding for long hypoglycemic action.
- Effect of three different injection sites on the pharmacokinetics of the once-daily human GLP-1 analogue liraglutide.
- Comprehensive analysis of LncRNAs expression profiles in an in vitro model of steatosis treated with Exendin-4.
- Individualised incretin-based treatment for type 2 diabetes.
- Lithocholic Acid-Based Peptide Delivery System for an Enhanced Pharmacological and Pharmacokinetic Profile of Xenopus GLP-1 Analogs.
- Exenatide once weekly for smoking cessation: study protocol for a randomized clinical trial.
- Comparing regional brain uptake of incretin receptor agonists after intranasal delivery in CD-1 mice and the APP/PS1 mouse model of Alzheimer's disease.
- Pharmacokinetic drug evaluation of exenatide for the treatment of type 2 diabetes.
- Effects of gamma-glutamyl linker on DPP-IV resistance, duration of action and biological efficacy of acylated glucagon-like peptide-1.
- Short-term semaglutide treatment improves FGF21 responsiveness in primary hepatocytes isolated from high fat diet challenged mice.
- Impact of Digital Engagement on Weight Loss Outcomes in Obesity Management Among Individuals Using GLP-1 and Dual GLP-1/GIP Receptor Agonist Therapy: Retrospective Cohort Service Evaluation Study.
- Insulin degludec/liraglutide: innovation-driven combination for advancement in diabetes therapy.
- Alternative dosing strategies for liraglutide in patients with type 2 diabetes mellitus.
- Cost Effectiveness of Exenatide Once Weekly Versus Insulin Glargine and Liraglutide for the Treatment of Type 2 Diabetes Mellitus in Greece.
- Comparative effectiveness of exenatide once-weekly versus liraglutide in routine clinical practice: A retrospective multicentre study and meta-analysis of observational studies.
- Heart rate increases in liraglutide treated chronic heart failure patients: association with clinical parameters and adverse events.
- Effect of exenatide therapy on hepatic fat quantity and hepatic biomarkers in type 2 diabetic patients.
- Exenatide Delays Gastric Emptying in Patients with Type 2 Diabetes Mellitus but not in Those with Gastroparetic Conditions.
- Safety of injectable semaglutide for type 2 diabetes.
- Exendin-4 improves behaviorial deficits via GLP-1/GLP-1R signaling following partial hepatectomy.